Drug Development

Hepatitis C clinical trial launched in India

Published in Hepatitis Weekly, October 17th, 2005

Aethlon Medical, Inc., (AEMD) announced that human clinical trials to treat patients infected with the hepatitis C virus (HCV) are now underway at the Apollo Hospital in New Delhi, India.

The primary objective of the trial is to demonstrate the safety of Aethlon's Hemopurifier treatment technology. The secondary objective of the trial will be to obtain preliminary efficacy data related to serologic and virologic markers, including viral load measurements before and after treatment with the Hemopurifier.

Aethlon chairman and CEO, James A. Joyce, stated, "Five years ago, our vision that a device could capture circulating viruses and toxins was purely...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2005-10-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry